Under the influence of technological, demographical and political factors, the world of healthcare is changing faster and more drastically than ever. Mediq, a leading player in health and home care across fourteen countries, responds by introducing new business models, initiatives and approaches to improve quality and affordability of care and, ultimately, the lives of millions of patients.
Mediq was founded in 1899 in the Netherlands. The private equity driven multinational has around 4000 employees and a leading position supplying medical devices, services and pharmaceuticals in every country in which it is active.
Over the coming years, Mediq’s market landscape will continue to change at an ever increasing rate. The challenge for the Corporate M&A and Business Development team is two-fold. Firstly, they will identify new business models that build on Mediq’s portfolio of strengths. The second part will be to execute organic and inorganic growth strategies to keep Mediq at the forefront of care for patients in hospital and, in particular, at home. Home care will see tremendous growth over the years to come, and Mediq will have a central position in defining and meeting this new reality.
Senior Manager Strategy and M&A
The Senior Manager is a member of the Corporate M&A and Business Development team (4 FTE). Across all current and future markets, this team is headed by Group Director Gerrit Webbink. There also is an opening for a Manager Strategy and M&A (minimum of four years of experience) within this team.
Mediq has positioned itself at the nexus of multiple vectors of innovation. The Senior Manager Strategy and M&A will have a central role in shaping Mediq’s evolution, working closely with the Executive Committee and supporting local Managing Directors and their leadership teams on strategic projects and M&A related activity.
Through strategic analysis, market landscaping, management of major, high-visibility internal projects, and deal sourcing, closing and integration, the Senior Manager will be at the forefront of major pillars of Mediq’s growth. A recent example of Mediq’s buy-and-build strategy is the acquisition of Globomedica, a leading direct-to-patient ostomy and specialty pharmaceuticals distributor in Switzerland.
Ideally, candidates will have a background in strategy consulting. Additional industry experience is an advantage. Candidates are analytical, strategic, pro-active and comfortable to work in a private equity driven environment. Maturity and authority are crucial to perform well during mergers and acquisitions and cooperation with C-level executives. Ambition is key: potential next steps could either be at HQ or towards local line management.